GW Pharmaceuticals (#GWP) – cancelled from trading on AIM
- 2016-12-05 00:53:23
UK 03:33 Friday, 30 October 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
A glance at the chart of GW Pharmaceuticals (GWP), the developer of Cannabis based cures for a variety of diseases, since its appearance on AIM some fifteen years ago perfectly demonstrates the fact that when it comes to ramping and promoting drug companies the health obsessed Americans have no equal.
From the FCA's spreadsheet of short positions required to be disclosed to it, the following details the shorted AIM shares (by net short position %) and if this position has increased (red), reduced (green) or remained unchanged (black) since a previous analysis HERE…
From the FCA's spreadsheet of short positions required to be disclosed to it, the following details the shorted AIM shares (by net short position %) and if this position has increased (red), reduced (green) or remained unchanged (black) since a previous analysis HERE…
From the FCA's spreadsheet of short positions required to be disclosed to it, the following details the shorted AIM shares (by net short position %) and if this position has increased (red), reduced (green) or remained unchanged (black) since a previous analysis HERE…
From the FCA's spreadsheet of short positions required to be disclosed to it, the following details the shorted AIM shares (by net short position %) and if this position has increased (red), reduced (green) or remained unchanged (black) since a previous analysis HERE…
From a technical perspective it can be said that the daily chart of GW Pharma (GWP) presents a quite pleasing picture, helped along by the aftermath of a golden cross buy signal between the 50 day and 200 day moving averages at the beginning of March.
Commissioned Researcher Edson reckons that it is a Long & Winding Road ahead for GW Pharma (GWP), the company trying to turn pot into medicines. But Edison sees Mr Blue Sky potential for the shares at 342p.
As a bonus feature the Closet Chartist has served up his six most exciting AIM TA situations of the week. His second duo are Nanoco (NANO) and GW Pharma (GWP).
Commissioned Researcher has today published a detailed buy note on its corporate client GW Pharmaceuticals (GWP) claiming that the shares could double.
